Bellevue Life Sciences Ac... (BLACU)
NASDAQ: BLACU
· Real-Time Price · USD
3.36
-3.74 (-52.68%)
At close: Feb 14, 2025, 3:54 PM
Company Description
Bellevue Life Sciences Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry.
The company was incorporated in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
| Country | United States |
| IPO Date | Feb 10, 2023 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Kuk Hyoun Hwang |
Contact Details
Address: 10900 NE 4th Street Bellevue, Washington United States | |
| Website | https://www.bellevuespac.com |
Stock Details
| Ticker Symbol | BLACU |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840425 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 84-5052822 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kuk Hyoun Hwang | Chief Executive Officer & Executive Chairman |
| David Jin Yoo | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 19, 2025 | PRE 14A | Filing |
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Aug 06, 2025 | 8-K | Current Report |
| Jul 25, 2025 | 8-K | Current Report |
| Jul 02, 2025 | 8-K | Current Report |
| Jun 27, 2025 | 424B3 | Filing |
| Jun 23, 2025 | 424B3 | Filing |
| Jun 10, 2025 | S-1/A | [Amend] Filing |
| May 28, 2025 | S-1 | Filing |
| May 20, 2025 | 10-Q | Quarterly Report |